37 results on '"Garcovich, M"'
Search Results
2. Hepatocellular carcinoma with portal vein tumor thrombus: a single-center retrospective analysis
3. P.09.30 NEW DIRECT-ACTING ANTIVIRAL (DAA) THERAPY IMPACTS LIVER STIFFNESS MEASUREMENTS IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS (HCV) INFECTION
4. P.09.10 CIRRHOTIC PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY PRESENT INCREASED CEREBRAL VASCULAR RESISTANCE, WHICH REMAINS UNCHANGED AFTER MEDICAL TREATMENT
5. P.16.15 FEASIBILITY AND ACCURACY OF ELASTPQ® SHEAR WAVE ELASTOGRAPHY TECHNIQUE AND DOPPLER INDICES IN THE NON-INVASIVE ASSESSEMENT OF LIVER FIBROSIS: A PRELIMINARY EXPERIENCE
6. P.16.9 SHORT TREATMENT WITH RIFAXIMIN IMPROVES BLOOD CEREBRAL FLOW AT TRANSCRANIAL DOPPLER AND PSYCHOMETRIC TESTS IN CIRRHOTIC PATIENTS WITH MINIMAL HEPATIC ENCEPHALOPATHY
7. P.16.8 ROLE OF TRANSCRANIAL DOPPLER (TCD) IN THE EVALUATION OF CEREBRAL HEMODYNAMIC IN CIRRHOTIC PATIENTS: CORRELATION WITH SEVERITY OF THE DISEASE AND MINIMAL HEPATIC ENCEPHALOPATHY (MHE) DEVELOPMENT
8. P.18.15 CONTRAST-ENHANCED ULTRASOUND EVALUATION OF TUMOR RESPONSE TO ANTI ANGIOGENETIC TREATMENT IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARINOMA
9. P.13.6 TREATMENT OF PORTAL VEIN TUMOR THROMBOSIS (PVTT) CAN IMPACT SURVIVAL OF PATIENTS WITH ADVANCED HCC?
10. P.11.20 CLINICAL OUTCOME OF PARTIAL PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS: TO OBSERVE OR TO TREAT?
11. P.11.18 GUT MICROBIOTA ALTERATION: THE LINK BETWEEN “LEAKY GUT” AND SPONTANEOUS BACTERIAL PERITONITIS IN LIVER CIRRHOTIC PATIENTS?
12. P.11.15 IMPACT OF PORTAL VEIN THROMBOSIS ON HEPATOCELLULAR CARCINOMA TREATMENT OUTCOME. THE HEPATOCAT GROUP EXPERIENCE
13. P.11.13 EPIDEMIOLOGY OF PORTAL AND DEEP VEIN THROMBOSIS IN HOSPITALIZED CIRRHOTIC PATIENTS: A SINGLE CENTER EXPERIENCE
14. F-34 Epidemiology of venous thrombotic events and pulmonary embolism among hospitalized cirrhotic patients: a single center experience
15. F-29 Endothelial dysfunction in cirrhosis and its relationship with portal hypertension and liver failure
16. O6 RELATIONSHIP BETWEEN SMALL INTESTINAL BACTERIAL OVERGROWTH AND INTESTINAL PERMEABILITY IN CIRRHOSIS
17. P.08.15 SYSTEMIC ENDOTHELIAL DYSFUNCTION AS A PREDICTOR OF HYPERTENSION DEVELOPMENT IN CIRRHOTIC PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) UNDERGOING THERAPY WITH SORAFENIB
18. P.08.13 REDUCED DOSE AND DURATION OF SORAFENIB TREATMENT ARE ASSOCIATED TO TUMOR PROGRESSION IN PATIENTS WITH HEPATOCELLULAR CARCINOMA
19. P.08.8 LACK OF RESPONSE AND TUMOR RECURRENCE AFTER MULTIMODAL REPEATED TREATMENT
20. P.07.11 REAL-TIME EVALUATION OF ALTERED GASTRIC MOTILITY BY ULTRASONOGRAPHY IN PATIENTS WITH PARKINSON'S DISEASE
21. P.04.16 TACROLIMUS ADMINISTRATION AND LIVER DISEASE ETIOLOGY INFLUENCE THE DEVELOPMENT OF FATTY CHANGES OF THE LIVER GRAFT AFTER LIVER TRANSPLANTATION
22. P.04.17 THE ROLE OF CONTRAST ENHANCED ULTRASOUND PERFUSION IMAGING AND DOPPLER INDICES IN THE NON-INVASIVE ASSESSEMENT OF LIVER FIBROSIS: A PRELIMINARY EXPERIENCE
23. P.04.12 NON INVASIVE EVALUATION OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH LIVER CIRRHOSIS: THE ROLE OF CONTRAST ENHANCED ULTRASOUND PERFUSION IMAGING AND DOPPLER ULTRASONOGRAPHY
24. P.03.17 SHORT-TERM EVALUATION OF HEPATOCELLULAR CARCINOMA AFTER SINGLE-STEP COMBINED TREATMENT: USEFULNESS OF CONTRAST-ENHANCED ULTRASONOGRAPHY
25. F-24 Short treatment with sorafenib is associated to tumor progression in patients with hepatocellular carcinoma
26. F-23 Lack of response and tumor recurrence after multimodal repeated treatment for hepatocellular carcinoma similarly affect HCC patients survival. A HEPATOCAT group experience
27. P.1.265: THE QUALITY AND ADEQUACY OF THE SPECIMEN OBTAINED BY PERCUTANEOUS LIVER BIOPSY IN LIVER TRANSPLANT RECIPIENTS: A SINGLE-CENTRE RETROSPECTIVE ANALYSIS
28. P.1.161: HCC PERSONALIZED TREATMENT IN THE MULTIMODAL MANAGEMENT ERA: HEPATOCAT GROUP EXPERIENCE
29. F-29 Reliability of serum creatinine in assessing renal function is reduced in patients with cirrhosis as compared with patients with organic renal disease
30. F-28 Systematic error in MELD calculation by using serum creatinine measurement in cirrhosis
31. F.N.12 BACTERIAL INFECTIONS IN CIRRHOSIS ARE ASSOCIATED WITH A POOR PROGNOSIS THAT IS NOT REFLECTED BY MELD AND UKELD SCORES
32. T.N.14 COLLAGEN PROPORTIONATE AREA IN ASSESSING THE AMOUNT OF FIBROSIS IN CHRONIC LIVER DISEASE: DOES HIGH RESOLUTION COMPARED TO CONVENTIONAL IMAGE CAPTURING AND ANALYSIS ALTERS ITS RESULTS?
33. T.N.13 PREDICTORS OF OUTCOME IN CIRRHOTICS ADMITTED TO INTENSIVE CARE UNIT (ICU); SURVIVORS EXHIBITED SIGNIFICANT RISE OF SERUM SODIUM LEVELS AND A FALL IN LACTATE LEVELS AT 48 HOURS
34. 51Cr-EDTA permeability test in ascitic cirrhotic patients with and without history of spontaneous bacterial peritonitis
35. PA.53 SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) IN PATIENTS WITH DUODENOGASTRIC REFLUX (DGR) POST-CHOLECYSTECTOMY
36. OC3.08.2 SMALL INTESTINAL BACTERIAL OVERGROWTH IN A CHILDREN POPULATION AFFECTED BY IRRITABLE BOWEL SYNDROME: A CASE-CONTROL STUDY
37. OC3.04.2 51CR-EDTA PERMEABILITY TEST IN ASCITIC CIRRHOTIC PATIENTS WITH AND WITHOUT HISTORY OF SPONTANEOUS BACTERIAL PERITONITIS
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.